Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith T Flaherty

Showing results (71-80 of 418) with videos related to

Pageof 42
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
The intersection of immune-directed and molecularly targeted therapy in advanced melanoma: where we have been, are, and will beRyan J Sullivan, Patricia M Lorusso, Keith T Flaherty
American Journal of Clinical Oncology|April 2, 2004
Phase I study of weekly liposome-encapsulated doxorubicin in patients with advanced, androgen-independent prostate cancerKeith T Flaherty, S Bruce Malkowicz, David J Vaughn
Cancer Discovery|November 15, 2014
Universes collide: combining immunotherapy with targeted therapy for cancerJennifer A Wargo, Zachary A Cooper, Keith T Flaherty
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
New options and new questions: how to select and sequence therapies for patients with metastatic melanomaKeith T Flaherty, Jeff A Sosman, Michael B Atkins
Cancer Research|April 9, 2009
Genetic subgrouping of melanoma reveals new opportunities for targeted therapyKeiran S M Smalley, Katherine L Nathanson, Keith T Flaherty
Journal of the National Cancer Institute|April 10, 2016
The Conundrum of Genetic "Drivers" in Benign ConditionsShumei Kato, Scott M Lippman, Keith T Flaherty, et al.
The Journal of Investigative Dermatology|January 6, 2012
Melanoma: new insights and new therapiesVasiliki A Nikolaou, Alexander J Stratigos, Keith T Flaherty, et al.
Nature Reviews. Clinical Oncology|April 5, 2017
Targeted agents and immunotherapies: optimizing outcomes in melanomaJason J Luke, Keith T Flaherty, Antoni Ribas, et al.
Nature Reviews. Cancer|November 6, 2015
Precision medicine for cancer with next-generation functional diagnosticsAdam A Friedman, Anthony Letai, David E Fisher, et al.
Cancer Discovery|September 3, 2016
High-Throughput Testing of Novel-Novel Combination Therapies for Cancer: An Idea Whose Time Has ComeUciane K Scarlett, Dennis C Chang, Thomas J Murtagh, et al.
Pageof 42

Showing results (71-80 of 418) with videos related to

Sort By:
Pageof 42
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
The intersection of immune-directed and molecularly targeted therapy in advanced melanoma: where we have been, are, and will beRyan J Sullivan, Patricia M Lorusso, Keith T Flaherty
American Journal of Clinical Oncology|April 2, 2004
Phase I study of weekly liposome-encapsulated doxorubicin in patients with advanced, androgen-independent prostate cancerKeith T Flaherty, S Bruce Malkowicz, David J Vaughn
Cancer Discovery|November 15, 2014
Universes collide: combining immunotherapy with targeted therapy for cancerJennifer A Wargo, Zachary A Cooper, Keith T Flaherty
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
New options and new questions: how to select and sequence therapies for patients with metastatic melanomaKeith T Flaherty, Jeff A Sosman, Michael B Atkins
Cancer Research|April 9, 2009
Genetic subgrouping of melanoma reveals new opportunities for targeted therapyKeiran S M Smalley, Katherine L Nathanson, Keith T Flaherty
Journal of the National Cancer Institute|April 10, 2016
The Conundrum of Genetic "Drivers" in Benign ConditionsShumei Kato, Scott M Lippman, Keith T Flaherty, et al.
The Journal of Investigative Dermatology|January 6, 2012
Melanoma: new insights and new therapiesVasiliki A Nikolaou, Alexander J Stratigos, Keith T Flaherty, et al.
Nature Reviews. Clinical Oncology|April 5, 2017
Targeted agents and immunotherapies: optimizing outcomes in melanomaJason J Luke, Keith T Flaherty, Antoni Ribas, et al.
Nature Reviews. Cancer|November 6, 2015
Precision medicine for cancer with next-generation functional diagnosticsAdam A Friedman, Anthony Letai, David E Fisher, et al.
Cancer Discovery|September 3, 2016
High-Throughput Testing of Novel-Novel Combination Therapies for Cancer: An Idea Whose Time Has ComeUciane K Scarlett, Dennis C Chang, Thomas J Murtagh, et al.
Pageof 42